Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.

Daniel Y, Hill K, Inusa B, Thein SL, Howard J.

Hemoglobin. 2011;35(4):406-10. doi: 10.3109/03630269.2011.592555.

PMID:
21797706
2.

Sickle cell disease in the Kurdish population of northern Iraq.

Al-Allawi NA, Jalal SD, Nerwey FF, Al-Sayan GO, Al-Zebari SS, Alshingaly AA, Markous RD, Jubrael JM, Hamamy H.

Hemoglobin. 2012;36(4):333-42. doi: 10.3109/03630269.2012.692344. Epub 2012 Jun 11.

PMID:
22686351
3.

Very mild pathology in a case of Hb S/beta0-thalassemia in combination with a homozygosity for the alpha-thalassemia 3.7 kb deletion.

Kerkhoffs JL, Harteveld CL, Wijermans P, van Delft P, Haak HL, Bernini LF, Giordano PC.

Hemoglobin. 2000 Aug;24(3):259-63. No abstract available.

PMID:
10975447
4.

Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region.

Amid A, Cheong M, Eng B, Hanna M, Hohenadel BA, Nakamura LM, Walker L, Odame I, Kirby-Allen M, Waye JS.

Haematologica. 2015 May;100(5):e166-8. doi: 10.3324/haematol.2014.117408. Epub 2015 Feb 14. No abstract available.

5.

High Hb A2 beta-thalassemia due to a 468 bp deletion in a patient with Hb S/beta-thalassemia.

Patterson M, Walker L, Eng B, Waye JS.

Hemoglobin. 2005;29(4):293-5.

PMID:
16370492
6.

Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients.

Koenig SC, Becirevic E, Hellberg MS, Li MY, So JC, Hankins JS, Ware RE, McMahon L, Steinberg MH, Luo HY, Chui DH.

Am J Hematol. 2009 Sep;84(9):603-6. doi: 10.1002/ajh.21480.

7.

Molecular characterization of a Chinese pedigree with beta-thalassemia intermedia.

Huang G, Jiang WL, Rong KB, Li YX, Luo XL, Meng JX, Yu XY.

Hemoglobin. 2010 Jan;34(2):179-83. doi: 10.3109/03630261003670226.

PMID:
20353356
8.

Coinheritance of Hb S [β6(A3)Glu→Val, GAG>GTG] with β0-thalassemia codon 17 (A>T) in a Thai patient.

Pornprasert S, Panyasai S, Kongthai K, Treesuwan K.

Hemoglobin. 2012;36(3):265-9. doi: 10.3109/03630269.2012.669358. Epub 2012 Apr 3.

PMID:
22471390
9.

Silent β-thalassemia mutations at -101 (C>T) and -71 (C>T) and their coinheritance with the sickle cell mutation in Bahrain.

Al Moamen NJ, Mahdi F, Salman E, Ahmed T, Abbas R, Al Arrayed S, Sanad H, Ahmed AA.

Hemoglobin. 2013;37(4):369-77. doi: 10.3109/03630269.2013.785434. Epub 2013 Apr 15.

PMID:
23586372
10.

Clinical and molecular characterization of β(S) and (G)γ((A)γδβ)⁰-thalassemia in eastern India.

Patel DK, Patel M, Mashon RS, Patel S, Dash PM, Das BS.

Hemoglobin. 2010;34(6):604-9. doi: 10.3109/03630269.2010.526890.

PMID:
21077771
11.

Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.

Muszlak M, Pissard S, Badens C, Chamouine A, Maillard O, Thuret I.

Hemoglobin. 2015;39(3):156-61. doi: 10.3109/03630269.2015.1023897. Epub 2015 Mar 25.

PMID:
25806420
12.

Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.

Andersson BA, Wering ME, Luo HY, Basran RK, Steinberg MH, Smith HP, Chui DH.

Eur J Haematol. 2007 Jan;78(1):82-5. Epub 2006 Oct 13.

PMID:
17038017
13.

β-globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sβ⁰-thalassemia and their association with clinical and hematological features.

Belisário AR, Martins ML, Brito AM, Rodrigues CV, Silva CM, Viana MB.

Acta Haematol. 2010;124(3):162-70. doi: 10.1159/000320271. Epub 2010 Oct 12. Erratum in: Acta Haematol. 2011;125(3):120.

PMID:
20938172
14.

Prenatal molecular diagnosis of β-thalassemia and sickle cell anemia in the Syrian population.

Murad H, Moassas F, Jarjour R, Mukhalalaty Y, Al-Achkar W.

Hemoglobin. 2014;38(6):390-3. doi: 10.3109/03630269.2014.978455.

PMID:
25405916
15.

Molecular basis of β-thalassemia in the western province of Saudi Arabia: identification of rare β-thalassemia mutations.

Abuzenadah AM, Hussein IM, Damanhouri GA, A-Sayes FM, Gari MA, Chaudhary AG, Zaher GF, Al-Attas A, Al-Qahtani MH.

Hemoglobin. 2011;35(4):346-57. doi: 10.3109/03630269.2011.588508.

PMID:
21797702
16.

THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.

Schmugge M, Waye JS, Basran RK, Zurbriggen K, Frischknecht H.

Hemoglobin. 2008;32(3):303-7. doi: 10.1080/03630260802004459.

PMID:
18473247
17.

Phenotype and genotype frequency of β-thalassemia and sickle cell disease carriers in Halkidiki, Northern Greece.

Kalleas C, Anagnostopoulos K, Sinopoulou K, Delaki E, Margaritis D, Bourikas G, Tsatalas C, Kortsaris A, Tentes I.

Hemoglobin. 2012;36(1):64-72. doi: 10.3109/03630269.2011.642489. Epub 2011 Dec 21.

PMID:
22188117
18.
19.

Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study.

Masmas TN, Garly ML, Lisse IM, Rodriques A, Petersen PT, Birgens H.

Hemoglobin. 2006;30(3):355-64.

PMID:
16840226
20.

Supplemental Content

Support Center